Decreased osteoclastogenesis, osteoblastogenesis and low bone mass in a mouse model of type 2 diabetes

Fei Xu1, Yonghui Dong1, Xin Huang1

  • 1Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, P.R. China.

Insights

Type 2 diabetes mellitus (T2DM) impairs bone metabolism, leading to reduced bone formation and resorption. This study in diabetic mice shows decreased bone mass and weakened biomechanics, suggesting T2DM contributes to osteoporosis.

Area of Science:

  • Endocrinology
  • Orthopedics
  • Metabolic Diseases

Background:

  • The impact of type 2 diabetes mellitus (T2DM) on bone health remains debated.
  • Investigating T2DM's role in osteoporosis is crucial for understanding its systemic effects.

Purpose of the Study:

  • To determine if T2DM causes osteoporosis.
  • To elucidate the mechanisms by which T2DM affects bone physiology.

Main Methods:

  • Utilized a KK-Ay mouse model of T2DM, comparing them to non-diabetic C57BL/6 mice.
  • Assessed bone parameters including weight, bone mineral density, osteoblast/osteoclast activity (von Kossa, TRAP staining, ALP/TRAP activity), and bone biomechanics (ultimate load).
  • Analyzed gene expression related to bone metabolism.

Main Results:

  • Diabetic mice showed hyperglycemia, hyperinsulinemia, increased body/fat weight, and reduced bone weight and bone mineral density in the femur, tibia, and lumbar vertebra.
  • Impaired osteoblastogenesis and osteoclastogenesis were observed in diabetic mice.
  • The ultimate load of the tibia was significantly lower in diabetic mice compared to controls.

Conclusions:

  • T2DM negatively impacts bone metabolism, characterized by reduced osteoblast and osteoclast activity.
  • These findings suggest T2DM contributes to decreased bone mass and potentially osteoporosis.
  • The study highlights the detrimental effects of T2DM on skeletal integrity.